» Articles » PMID: 37761353

Ultrasonographic Presentation and Anatomic Distribution of Lung Involvement in Patients with Rheumatoid Arthritis

Overview
Specialty Radiology
Date 2023 Sep 28
PMID 37761353
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Rheumatoid arthritis (RA) is a chronic auto-immune disease, typically affecting the joints, which can also present with lung involvement (pleuritis, interstitial lung disease, pulmonary nodules, etc.). Lung ultrasound (LUS) is an upcoming tool in the detection of these pulmonary manifestations.

Methods: We performed a 72-window LUS in 75 patients presenting to the outpatient rheumatology clinic and describe the abnormalities (presence of B-lines (vertical comet-tail artefacts), pleural abnormalities, pleural effusions, and subpleural nodules) on lung ultrasound. We created a topological mapping of the number of B-lines per intercostal zone.

Results: We observed pleural effusions, pleural abnormalities, and pleural nodules in, respectively, 1.3%, 45.3%, and 14% of patients. There were 35 (46.7%) patients who had less than 5 B-lines, 15 (20%) patients who had between 5 and 10 B-lines, 11 (14.6%) between 10 and 20, 10 (13.3%) between 20 and 50, 1 (1.3%) between 50 and 100, and 3 (4%) of patients who had more than 100 B-lines.

Conclusions: LUS in patients with RA shows an array of abnormalities ranging from interstitial syndromes to pleural abnormalities, subpleural nodules, and pleural effusions. Hotspots for the presence of B-lines are situated bilaterally in the posterior subscapular regions, as well as the anterior right mid-clavicular region.

Citing Articles

The Burden of Interstitial Lung Involvement in Rheumatoid Arthritis: Could Lung Ultrasound Have a Role in Its Detection? A Literature Review.

Lepri G, Markovic M, Bellando-Randone S, Sebastiani M, Guiducci S Diagnostics (Basel). 2024; 14(13).

PMID: 39001320 PMC: 11241826. DOI: 10.3390/diagnostics14131430.

References
1.
Fairchild R, Chung M, Yang D, Sharpless L, Li S, Chung L . Development and Assessment of Novel Lung Ultrasound Interpretation Criteria for the Detection of Interstitial Lung Disease in Systemic Sclerosis. Arthritis Care Res (Hoboken). 2020; 73(9):1338-1342. PMC: 9176687. DOI: 10.1002/acr.24338. View

2.
Lee H, Kim D, Yoo B, Seo J, Rho J, Colby T . Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest. 2005; 127(6):2019-27. DOI: 10.1378/chest.127.6.2019. View

3.
Johnson T, Yang Y, Roul P, Sauer B, Cannon G, Kunkel G . A Narrowing Mortality Gap: Temporal Trends of Cause-Specific Mortality in a National Matched Cohort Study in US Veterans With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2022; 75(8):1648-1658. PMC: 10275614. DOI: 10.1002/acr.25053. View

4.
Bruni C, Mattolini L, Tofani L, Gargani L, Landini N, Roma N . Lung Ultrasound B-Lines in the Evaluation of the Extent of Interstitial Lung Disease in Systemic Sclerosis. Diagnostics (Basel). 2022; 12(7). PMC: 9316638. DOI: 10.3390/diagnostics12071696. View

5.
Vicente-Rabaneda E, Bong D, Castaneda S, Moller I . Use of ultrasound to diagnose and monitor interstitial lung disease in rheumatic diseases. Clin Rheumatol. 2021; 40(9):3547-3564. DOI: 10.1007/s10067-021-05761-0. View